Northern Antibiotics has a pipeline of direct acting antibiotics derived from polymyxin B that aim to retain the antibiotic activity, but with a much broader therapeutic window. In preclinical ...

The latter ensures that harmful molecules do not permeate the bacterial cell, but polymyxin B (PmB), a last-resort antibiotic, is capable of interfering with the stability of the LPS layer and ...